Clin2
NCT06650163Possibly a fitRecruiting

New imaging test for brain tumor surgery planning

GliomaMalignant Brain NeoplasmMeningiomaMetastatic Malignant Neoplasm in the Brain

Part of Brain & nervous system, Cancer clinical trials.

This trial tests a new kind of PET scan that uses a special tracer (Zr-89 crefmirlimab berdoxam) to help doctors see brain tumors more clearly before surgery. If you are scheduled to have your brain tumor removed, this scan may give your surgeon extra information to guide the operation.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have been diagnosed with a brain tumor (including metastatic tumors, gliomas, or meningiomas)
  • You are already scheduled to have surgery to remove the tumor
  • You are able to have an MRI and a PET/CT scan
  • Your kidney and liver function are within certain safe ranges

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05386043Recruiting
Study brain tumor testing with MRI and extra tissue samples

This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.

Indianapolis, Indiana
NCT03739411Recruiting· Phase 1
MRI scan with a special agent to assess brain tumors

This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.

San Francisco, California
NCT07778979Not yet recruiting· Early Phase 1
PET/MRI scans to map brain tumor activity

This study uses special PET and MRI scans to map the activity and oxygen levels of brain tumors (gliomas). The results help doctors plan treatment that is more tailored to each patient.

Birmingham, Alabama
NCT06667726Recruiting· Phase 2
New PET scan for better brain tumor care

This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.

Rochester, Minnesota
NCT07218367Not yet recruiting· Phase 1
Study of new imaging before brain surgery for glioblastoma

This trial looks at a new imaging method to help doctors see brain tumors more clearly before surgery. It may help remove the tumor more safely and completely.

West Los Angeles, California
NCT07106008Not yet recruiting
Imaging brain tumors with a special tracer

This trial tests a new imaging tracer that may help doctors see brain tumors (gliomas) more clearly before surgery. It could help guide treatment and is for people scheduled for surgery or biopsy.

Hear when a new Glioma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.